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INTRODUCTION 
 
There are two mosquito-borne diseases of concern in Massachusetts, Eastern equine encephalitis 
(EEE), which was identified as a human disease in 1938, and West Nile virus (WNV) infection, 
which has been present in the United States since 1999. EEE is a rare but serious neuroinvasive 
disease that causes meningitis or encephalitis, and often results in death or severe disability. 
WNV infection is more common, though typically less severe than EEE; presentation of WNV 
ranges from febrile illness to neuroinvasive disease. Although 51 different species of mosquitoes 
have been identified in Massachusetts, only a few of these contribute to either WNV or EEE 
spread. For more information, visit the MDPH website to view Common Mosquitoes That Can 
Spread Disease in Massachusetts. 
 
Currently, there are no available vaccines to prevent human infections from either mosquito-
borne virus. Personal protection measures that serve to reduce exposure to mosquitoes and 
thereby prevent human infection remain the mainstay of prevention. To estimate the risk of 
human disease during a mosquito season, the MDPH, in cooperation with the local Mosquito 
Control Projects, conducts surveillance for EEE and WNV using mosquito samples, and 
specimens from human and veterinary sources. Detailed information about surveillance for these 
diseases in Massachusetts is available on the MDPH website at Arbovirus Surveillance and 
Control Plan. 
 
EASTERN EQUINE ENCEPHALITIS VIRUS 
 
Humans 
No human cases of EEE virus infection have been identified in Massachusetts since 2013. 
 
Mosquito Samples 
Of 5,921 mosquito samples tested in Massachusetts in 2018, two samples (0.03%) were positive 
for EEE virus in 2018. The positive samples were identified in the towns of Hubbardston and 
Lakeville. For a complete list of positive mosquito samples by city/town, please see the 2018 
Mosquito Summary by County and Municipality report posted on the MDPH website. 
 
Animals  
Fourteen samples were submitted for arbovirus testing.  There were two animals that tested 
positive for EEE virus infection in 2018, a turkey in Hubbardston and a horse in East Brookfield. 
 
 
Birds 
Although birds are not routinely tested as part of EEE surveillance, species such as emus or exotic 
quail may experience sudden illness and mortality due to EEE. Farmed birds showing these signs 
must be reported promptly to the Massachusetts Department of Agricultural Resources (MDAR). 
A wild turkey in Hubbardston was reported in 2018 and tested positive for EEE. 
 
EEE Geographic Risk Levels 
EEE risk maps combine historical data and areas of mosquito habitat with current data on 
positive virus isolations (in humans, mosquitoes, etc.) and weather conditions. Risk levels are an 
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estimate of the likelihood of an outbreak of human disease and are updated weekly based on 
surveillance data.  Initial and final EEE risk levels from the 2018 season are shown in the 
following maps. This information will be used to help anticipate risk in 2019, and will be revised 
as 2019 surveillance data are collected. More detailed information about risk assessment and risk 
levels is available in the Arbovirus Surveillance and Response Plan on the MDPH web site. 
 
 
Initial and Final 2018 EEE Risk Categories 
 
 (As defined in Table 2 of the MDPH Arbovirus Surveillance and Response Plan which can be 
found at www.mass.gov/dph/mosquito under “Surveillance Summaries and Data”) 
 
 
 
 
 
 
2018 EEE SEASON DISCUSSION 
There were no confirmed human EEE cases in 2018 or 2017, compared to seven confirmed 
human cases in 2012 and one in 2013; 2012 was the most recent outbreak year in Massachusetts. 
The number of confirmed human cases nationwide was lower in 2018 (five) and 2017 (five) 
when compared to 2012 (15).   
 
There was a similar decline in EEE virus positive mosquito samples from 267 in 2012 to two in 
2018. In 2018, MDPH identified two EEE positive sample of Culiseta melanura, the enzootic 
vector of EEE. Mosquito surveillance activities are highly adaptive to identifications of EEE 
virus, with more mosquito trapping and testing in years when EEE activity is increased, this 
makes year-to-year comparisons somewhat difficult. In general, years with increased EEE 
human infections are associated with an increase in the percentage of Cs. melanura samples 
positive for EEE virus (see figure below).  
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Why has there been less EEE activity since 2012?  
Historically, EEE outbreaks have rarely occurred during periods lasting more than three years, 
although evidence suggests that previously observed patterns may be changing and the situation 
must be monitored carefully. Intense EEE activity consistent with outbreaks occurred in 2004-
2006 and 2010-2012. Outbreaks are probably supported, in part, by previously unexposed 
populations of birds that are susceptible to EEE virus infection, and therefore capable of 
maintaining the cycle of virus transmission. Current research also suggests that each of these 
cycles is associated with the introduction of a new strain of EEE virus by migratory birds. After 
three years (2010-2012) of intense virus activity, the population of susceptible birds may not 
have been adequate to maintain the virus cycle in more recent years. Important factors also 
impacting EEE virus cycles include large Cs. melanura mosquito populations which are more 
likely to support significant EEE activity, and weather conditions, such as significant 
precipitation events and prolonged periods of high temperature. In 2012, significant precipitation 
and prolonged periods of high temperatures provided favorable conditions for mosquito 
development. In 2017, average precipitation in winter, spring, and summer combined with 
above-average summer temperatures increased available breeding habitat for the traditional 
vectors of EEE and led to above average mosquito abundance rates throughout the breeding 
season. In 2018, the mosquito season began with above average precipitation events. 
Precipitation events remained consistently above average and summer temperatures were above 
average for the entire breeding season. Breeding habitat for Cs. melanura increased compared to 
prior years with abundance levels of Cs. melanura fully rebounding from the impact of drought 
conditions seen in 2016.   
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Variability in Geographic Range of EEE 
In Massachusetts over the last ten years, some human EEE cases have occurred outside of the 
historic area of risk and there have been year-to-year variations in the geographic pattern of 
disease occurrence. This is not unique to Massachusetts; during 2013-2016, human cases of EEE 
were reported from neighboring states including Connecticut, Maine, New Hampshire, New 
York, Rhode Island, and Vermont. Many of these cases were unusual in that they occurred in: 
states which rarely see EEE cases (Connecticut and Rhode Island); states where EEE cases are a 
very recent occurrence (Maine, New Hampshire and Vermont); and in atypical areas in states 
that have historic areas of risk (New York). MDPH continues to perform adaptive surveillance 
activities to provide for early detection of EEE throughout the Commonwealth.    
 
                                   
What are the expectations for EEE in 2019? 
Mosquito abundance and vector-borne disease risk are affected by multiple environmental 
factors which vary over time and geographic location. The two most important contributors to 
mosquito development are precipitation and temperature. All species of mosquito depend on the 
presence of water for the first stages of life. Mosquito populations increase when precipitation is 
plentiful and decrease during dry periods. Warmer temperatures shorten both the time it takes for 
mosquitoes to develop from egg to adult and the time it takes for a mosquito to be able to 
transmit pathogens after ingesting an infected blood meal. 
 
Warm and wet winters increase the likelihood of mosquito survival and may lead to higher 
spring mosquito numbers. The summer and fall of 2018 brought above average temperatures and 
precipitation events leading to extensive breeding habitat for the traditional vectors of EEE. A 
preliminary assessment of the winter of 2018-2019 has average temperatures combined with 
above average precipitation events. Early reports from the field indicate above average numbers 
of juvenile Cs. melanura. 
 
Mosquito populations alone are not sufficient to produce significant EEE risk; infected bird 
populations are also necessary.  Unfortunately, less is known about the factors that lead to large 
numbers of infected birds, making this component of risk impossible to predict. At this time 
there is no efficient method to conduct surveillance for infection levels in wild birds.  
 
In Massachusetts, human EEE 
infection is associated with 
Culiseta melanura activity. The 
map to the right illustrates that 
one area at highest risk for 
transmission of EEE is 
Southeastern Massachusetts 
which has also been the historic 
area of risk. Northeastern 
Massachusetts has become an 
area of high risk more recently. 
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Both the variability of New England weather and the inability to detect EEE virus infection 
levels in wild bird populations require that Massachusetts maintain a robust surveillance system 
every year to detect EEE virus in mosquitoes as a tool to assess risk of human disease. 
 
WEST NILE VIRUS  
 
Humans 
There were forty-nine human cases of WNV infection identified in Massachusetts in 2018. The 
results are summarized in the table below. 
 
County Age Range Onset Date Virus Result Clinical Presentation 
Barnstable 81-90 8/30/2018 WNV Fever 
Barnstable 61 - 70 9/16/2018 WNV Meningoencephalitis 
Barnstable 71-80 9/28/2018 WNV Encephalitis 
Barnstable 71-80 10/28/2018 WNV Meningitis 
Berkshire 61 - 70 8/26/2018 WNV Encephalitis 
Bristol 61 - 70 8/18/2018 WNV Meningoencephalitis 
Bristol 51-60 9/1/2018 WNV Meningoencephalitis 
Essex 21 - 30 8/21/2018 WNV Meningitis 
Essex 71 - 80 8/26/2018 WNV Meningitis 
Essex 61 - 70 8/27/2018 WNV Meningoencephalitis 
Essex 61-70 8/31/2018 WNV Meningoencephalitis 
Essex 41-50 9/17/2018 WNV Fever 
Essex 71-80 9/21/2018 WNV Meningitis 
Essex 81-90 9/26/2018 WNV Encephalitis 
Essex 51-60 10/9/2018 WNV Meningoencephalitis 
Franklin 71-80 9/19/2018 WNV Encephalitis 
Hampshire 71-80 9/12/2018 WNV Meningitis 
Hampshire 71-80 10/1/2018 WNV Meningoencephalitis 
Middlesex 61-70 7/23/2018 WNV Fever 
Middlesex 51-60 8/1/2018 WNV Meningitis 
Middlesex 71-80 8/19/2018 WNV Meningitis 
Middlesex 31 - 40 8/21/2018 WNV Fever 
Middlesex 31-40 8/23/2018 WNV Meningitis 
Middlesex 61 - 70 8/24/2018 WNV Meningitis 
Middlesex 21 - 30 8/30/2018 WNV Meningitis 
Middlesex 61 - 70 9/3/2018 WNV Meningoencephalitis 
Middlesex 61 - 70 9/4/2018 WNV Fever 
Middlesex 71-80 9/5/2018 WNV Encephalitis 
Middlesex 41-50 9/8/2018 WNV Meningitis 
Middlesex 61 - 70 9/17/2018 WNV Meningoencephalitis 
Middlesex 51 - 60 9/18/2018 WNV Encephalitis 
Middlesex 31 - 40 9/21/2018 WNV Meningitis 
Middlesex 51 - 60 9/22/2018 WNV Fever 
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Middlesex 51 - 60 9/24/2018 WNV Meningitis 
Middlesex 61 - 70 9/27/2018 WNV Meningitis 
Norfolk 61 - 70 9/16/2018 WNV Meningitis 
Plymouth 61 - 70 9/15/2018 WNV Encephalitis 
Plymouth 61 - 70 10/8/2018 WNV Meningitis 
Suffolk 61 - 70 7/28/2018 WNV Encephalitis 
Suffolk 41 - 50 8/12/2018 WNV Encephalitis 
Suffolk 81 - 90 8/17/2018 WNV Meningoencephalitis 
Suffolk 51 - 60 8/23/2018 WNV Encephalitis 
Suffolk 61 - 70 9/2/2018 WNV Meningitis 
Suffolk 31 - 40 9/4/2018 WNV Meningoencephalitis 
Suffolk 51 - 60 9/12/2018 WNV Meningitis 
Suffolk 81 - 90 9/13/2018 WNV Meningitis 
Suffolk 51 - 60 9/17/2018 WNV Encephalitis 
Worcester 71 - 80 8/10/2018 WNV Meningitis 
Worcester 41 - 50 9/20/2018 WNV Meningitis 
 
Presumptive Viremic Blood Donors 
WNV is transmissible through blood transfusion. Since June 2003, blood banks have screened 
donated blood for WNV using a nucleic acid test (NAT) that identifies viral genetic material. 
Positive units are not used and donors are deferred from future donation for 120 days. The 
AABB (formerly the American Association of Blood Banks) notifies states of all presumptive 
viremic donors (PVDs), i.e., individuals whose donated blood tests positive using the NAT test. 
 
There were two PVD identified in Massachusetts in 2018. The number of PVDs nationwide 
increased in 2018 (357) from 2017 (247). 
 
 
 
 
 
 
 
Mosquito Samples 
Of 5,921 mosquito samples collected in Massachusetts in 2018, 579 (9.8%) were positive for 
WNV. Positive mosquito samples included 522 (90%) Culex species.  Positive samples were 
identified in 153 towns in 13 counties. For a complete list of positive mosquito samples by 
city/town, please see the 2018 Mosquito Summary by County and Municipality report posted on 
the MDPH website. 
 
Animals 
Fourteen veterinary samples were submitted for arbovirus testing. There were two animals that 
tested positive for WNV in 2018, a horse in Bernardston and a horse in Granby. 
 
 
 
 
County Donation Date Virus Result  
Barnstable 8/27/2018 WNV 
Bristol  9/22/2018 WNV 
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WNV Geographic Risk Levels 
WNV risk maps are produced by integrating historical data and areas of mosquito habitat with 
current data on positive virus identifications (in humans, mosquitoes, etc.) and weather 
conditions. Risk levels serve as a relative measure of the likelihood of an outbreak of human 
disease and are updated weekly based on that week’s surveillance data. Initial and final WNV 
risk levels from the 2018 season are provided in the following maps. This information will be 
used to help predict risk in 2019, and will be revised as 2019 surveillance data are collected. 
More detailed information about risk assessment and risk levels is available in the Arbovirus 
Surveillance and Response Plan on the MDPH web site during the arbovirus season. 
 
Initial and Final 2018 WNV Risk Categories 
 (As described in Table 1 of the MDPH Arbovirus Surveillance and Response Plan which can be 
found at www.mass.gov/dph/mosquito under “Surveillance Summaries and Data”) 
 
                                                                  
  
2018 WNV SEASON DISCUSSION 
MDPH identified forty-nine confirmed human WNV infections in 2018 compared to six 
confirmed WNV cases in 2017. The 2018 WNV season stands out as the highest annual human 
case count since WNV arrived in MA in 2001. Above average precipitation events coupled with 
above average temperatures created conditions favorable to container breeding Culex mosquito 
species which transmit WNV.  The number of confirmed human cases nationwide in 2018 
(2,544) was an increase from 2017 (2,002) but far fewer than the 2012 outbreak (5,674).    
   
Of the cases identified nationally in 2018, 1,594 (63%) were classified as neuroinvasive disease 
(defined as meningitis or encephalitis) and 950 (37%) were classified as non-neuroinvasive 
disease. A major portion of the cases (33%) were reported from four states (Nebraska, 
California, North Dakota and Illinois). 10% of all cases were reported from Nebraska.  
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WNV Positive Mosquitoes and Correlation with Human Disease 
In 2018, MDPH identified 522 WNV positive Culex species mosquito samples compared to 277 
WNV positive Culex species mosquito samples in 2017. In general, years with increased WNV 
human infections are associated with an increase in the percentage of Culex samples positive for 
WNV (see figure below). Considering the increase in human cases of WNV infection that 
occurred from 2014-2016, an increase in WNV positive mosquito samples might be expected. As 
the graph below demonstrates, the percentage of WNV positive Culex mosquito samples 
decreased sharply from a peak in 2012, associated with a notably hot summer resulting in a 
national outbreak, to a low in 2014 with an uptick in 2015, 2016 and 2017. In 2018 the increase 
in confirmed human cases compared to WNV positive mosquito samples matched the expected 
trend.   
 
 
 
 
 
In Massachusetts, the vectors for WNV are 
primarily Culex species. Culex species are 
closely associated with human activity. The 
map to the right illustrates that transmission 
to humans is generally highest in counties 
with higher population densities. 
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What are the expectations for WNV in 2019? 
The primary determinants of human WNV disease risk during any particular season are 
populations of Culex mosquito species and the presence of infected birds. The two most 
important variables for mosquito development are precipitation and temperature. Warmer 
temperatures shorten both the time it takes for mosquitoes to develop from egg to adult and the 
time it takes for a mosquito to be able to transmit a pathogen after ingesting an infected blood 
meal. Culex mosquito populations tend to be greatest during seasons with periodic precipitation 
events (giving rise to stagnant puddles and containers that favor Culex breeding), separated by 
hot, dry days  
 
Mosquito populations alone are not sufficient to produce significant WNV risk; infected bird 
populations are also necessary. Unfortunately, less is known about the factors that lead to large 
numbers of infected birds making this component of risk impossible to predict and there is no 
efficient way to conduct surveillance for infection levels in wild birds.  
 
The lack of useful pre-season predictive factors limits the ability of MDPH to make any accurate 
assessments regarding future WNV activity. Both the variability of New England weather, and 
the inability to detect WNV infection levels in wild bird populations, requires that Massachusetts 
maintain a robust surveillance system to detect WNV in mosquitoes as a primary tool to assess 
risk of human disease. MDPH continues to strive to identify reliable measures to aid in risk 
assessments.   
 
Invasive Mosquito Species Surveillance 
 
MDPH and its partners are taking proactive measures to conduct surveillance for invasive 
mosquito species that are expanding their geographic range northward, especially for 
Aedes albopictus. Ae. albopictus is an aggressive mammal-biting species that was introduced to 
North America from Asia around 1985. This species has been implicated in the transmission 
of arboviruses such as dengue, chikungunya, yellow fever, and Zika, in some parts of the world. 
Where it occurs, this species is generally more abundant in urban areas, breeding in artificial 
containers, such as birdbaths, discarded tires, buckets, clogged gutters, catch basins, and other 
standing water sources. These mosquitoes are aggressive biters that actively seek out mammals, 
including humans, during daytime hours. 
 
          
Zika Virus Surveillance 
Limited detections of Ae. albopictus 
were first identified in Southeastern 
MA in 2009. Since these initial 
detections, additional findings have 
been recorded outside Southeastern 
MA. With the use of ovitraps Ae. 
albopictus has now been detected in 20 
communities throughout the state since 
2009. MDPH will continue to conduct 
routine surveillance activities to 
monitor for the presence and 
expansion of Ae. albopictus and other 
invasive mosquito species.          
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The global Zika virus outbreak began in South America in December 2015. Throughout 2016 – 
2017 Zika virus spread across much of the globe. In 2018 the Zika virus outbreak diminished 
substantially worldwide. Zika virus is transmitted by Aedes mosquitoes. Symptoms appear in 
only 20% of cases, the majority of patients experience no symptoms. Those individuals that do 
experience symptoms typically have low-grade fever, muscle and or joint pain, rash, 
conjunctivitis, nausea, and diarrhea. The disease resolves with supportive treatment. However, in 
pregnant women who become infected with Zika virus, it is possible for the virus to spread to the 
developing fetus. When this happens, it can result in birth defects, including abnormal brain and 
head development (microcephaly). 
 
In 2018, the Massachusetts State Public Health Laboratory tested 360 residents for Zika virus 
compared to 3,013 in 2017. Of the 360 samples submitted for testing seven (1.9%) were positive. 
All cases were investigated and determined to be travel associated. There have been no cases of 
Zika virus acquired locally from mosquitoes in Massachusetts. Since Zika virus is not a locally 
transmitted mosquito-borne disease, there are no plans to test mosquitoes in Massachusetts for 
Zika virus.  
 
   
 
